Stock Rich List
#527 on the rich list of 14,644 insiders

Neil Kumar

Chief Executive Officer at BridgeBio Pharma. Based in Palo Alto, California.

$439M
in disclosed stock, +$2.5M (+0.58%) today
Live prices, last trade 2:45 PM ET
Rank
527th of 14,644
Companies held
1
Largest holding
BBIO, 100.0% of total
Latest SEC filing
Nov 16, 2026

What the $439M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
BridgeBio Pharma BBIO
Common Stock
Through Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.3,568,447$78.46$280M63.7%Form 4, Nov 16, 2026
BridgeBio Pharma BBIO
Common Stock
Through NK 2026 GRAT750,000$78.46$58.8M13.4%Form 4, Nov 16, 2026
BridgeBio Pharma BBIO
Common Stock
Indirectly (see filing footnote)505,686$78.46$39.7M9.0%Form 4, Aug 19, 2026
BridgeBio Pharma BBIO
Common Stock
Through Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.495,686$78.46$38.9M8.9%Form 4, Nov 16, 2026
BridgeBio Pharma BBIO
Common Stock
Directly278,307$78.46$21.8M5.0%Form 4, Nov 16, 2026

Share counts are the amounts Neil Kumar reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 17, 2026SoldBBIO1,279$69.57$89KView
Sep 17, 2026SoldBBIO8,721$69.01$602KView
Aug 19, 2026SoldBBIO100$85.65$9KView
Aug 19, 2026SoldBBIO1,800$84.69$152KView
Aug 19, 2026SoldBBIO8,100$83.86$679KView
Aug 18, 2026SoldBBIO14,602$82.99$1.2MView
Aug 18, 2026SoldBBIO1,900$81.15$154KView
Aug 18, 2026SoldBBIO17,279$82.21$1.4MView
Aug 18, 2026SoldBBIO1,199$83.77$100KView
Jun 5, 2026SoldBBIO7,147$67.20$480KView
Jun 5, 2026SoldBBIO4,415$68.96$304KView
Jun 5, 2026SoldBBIO4,416$68.96$305KView
Jun 5, 2026SoldBBIO8,437$67.88$573KView
Jun 5, 2026SoldBBIO8,437$67.88$573KView
Jun 5, 2026SoldBBIO7,148$67.20$480KView
Jun 4, 2026SoldBBIO2,200$65.72$145KView
Jun 4, 2026SoldBBIO1,429$66.72$95KView
Jun 4, 2026SoldBBIO15,921$67.74$1.1MView
Jun 4, 2026SoldBBIO450$68.27$31KView
Jun 4, 2026SoldBBIO2,200$65.72$145KView
Jun 4, 2026SoldBBIO1,429$66.72$95KView
Jun 4, 2026SoldBBIO15,921$67.74$1.1MView
Jun 4, 2026SoldBBIO450$68.27$31KView
May 21, 2026SoldBBIO800$70.92$57KView
May 21, 2026SoldBBIO2,256$67.57$152KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
524Philip H. Knight
Insider, NIKE. Beaverton, OR
$441M−$24.6M (−5.27%)
525Yair Nechmad
CEO, Co Founder & Chairman, Nayax
$441M−$13.3M (−2.93%)
526Yoshiyuki Aikawa
Chairman and CEO, SBC Medical Group Holdings. Irvine, CA
$441M−$58.6M (−11.72%)
527Neil Kumar
Chief Executive Officer, BridgeBio Pharma. Palo Alto, CA
$439M+$2.5M (+0.58%)
528P. Roy Vagelos
Director, Regeneron Pharmaceuticals. Tarrytown, NY
$435M−$6.7M (−1.51%)
529Ira Ehrenpreis
Director, Tesla. Starbase, TX
$435M−$9.5M (−2.13%)
530Jonathan Gray
President & COO, Blackstone. New York, NY
$434M+$5.2M (+1.22%)

Other BridgeBio Pharma insiders

All BBIO insiders

Questions

How much stock does Neil Kumar own?

Neil Kumar holds $439,228,966 in listed stock based on SEC filings and current prices, mostly BridgeBio Pharma (BBIO). That ranks 527th on the Stock Rich List.

Is this Neil Kumar's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Neil Kumar last buy or sell stock?

The most recent open-market trade on file is a sale of 1,279 BBIO shares on Sep 17, 2026 at $69.57.